Published on November 3, 2015

India is among the top six global pharmaceutical producers in the world. Indian vaccines are exported 150 countries. India produces 40-70% of WHO demand for DPT & BCG AND 90% of measles vaccine. Around 70% of patients in developing countries receive Indian Medicines through NGOs like the Clinton Foundation, Bill & Melinda Gates Foudation, etc

Recently, Drug major Dr Reddy’s Laboratories has launched a pain a relief spray under ‘Nise D Spray’ as part of its plans to bolster presence in Indian market. The spry will be available across the country in two sizes –pocket pack at Rs.99 and home pack for Rs 130, recently declared by the company. The market for pain relief product in India is Aporoximately Rs.1700 crore.

Indian Pharmaceutical sector is expected to reach USD 55 billion by 2020. India is well places to become one of the major driver in providing healthcare to all while controlling the ever increasing healthcare spend of both developed and developing nations.